Skip to main content
Erschienen in: Acta Neuropathologica 3/2004

01.09.2004 | Regular Paper

Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study

verfasst von: Enikö Kövari, Gabriel Gold, Panteleimon Giannakopoulos, Constantin Bouras

Erschienen in: Acta Neuropathologica | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Ubiquitin-positive tau-negative inclusions were initially described in the rare form of frontotemporal dementia (FTD) associated with motor neuron disease. However, recent studies have indicated that these inclusions are also present in typical FTD, which is usually characterized by nonspecific histological changes. To examine the contribution of these inclusions to neuronal loss and to explore their relationship with disease duration, we performed a quantitative immunocytochemical analysis of 38 typical FTD cases. Relationships between neuron and ubiquitin inclusion densities as well as between duration of illness and neuropathological parameters was studied using linear regression in both univariate and multivariate models. Ubiquitin-positive tau-negative intracytoplasmic inclusions were present in 65.8% of cases in the dentate gyrus, 57.9% in temporal cortex and 31.6% in frontal cortex. The highest densities of ubiquitin-positive inclusions were consistently observed in the dentate gyrus, followed by the temporal and frontal cortex. There was no statistically significant relationship between neuron and ubiquitin-positive inclusion densities in any of the areas studied. In contrast, ubiquitin-positive inclusion densities in the dentate gyrus were negatively related to the duration of illness. Our data suggest that the development of ubiquitin-related pathology is the rule and not the exception in typical FTD, yet is not causally related to neuronal loss. They also reveal that the development of ubiquitin-positive inclusion densities in the dentate gyrus may be associated with a more aggressive form of the disease.
Literatur
1.
Zurück zum Zitat Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME (1998) Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516–520PubMed Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME (1998) Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516–520PubMed
2.
Zurück zum Zitat Bergmann M, Kuchelmeister K, Schmid KW, Kretzschmar HA, Schroder R (1996) Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol 92:170–179CrossRefPubMed Bergmann M, Kuchelmeister K, Schmid KW, Kretzschmar HA, Schroder R (1996) Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol 92:170–179CrossRefPubMed
3.
Zurück zum Zitat Bigio EH, Lipton AM, White CL 3rd, Dickson DW, Hirano A (2003) Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253CrossRefPubMed Bigio EH, Lipton AM, White CL 3rd, Dickson DW, Hirano A (2003) Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 29:239–253CrossRefPubMed
4.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed
5.
Zurück zum Zitat Brun A, Englund B, Gustafson L, Passant U, Mann D, Neary D, Snowden JS (1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57:416–418PubMed Brun A, Englund B, Gustafson L, Passant U, Mann D, Neary D, Snowden JS (1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57:416–418PubMed
6.
Zurück zum Zitat Cairns NJ, Brannstrom T, Khan MN, Rossor MN, Lantos PL (2003) Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Exp Neurol 181:319–326CrossRefPubMed Cairns NJ, Brannstrom T, Khan MN, Rossor MN, Lantos PL (2003) Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Exp Neurol 181:319–326CrossRefPubMed
7.
Zurück zum Zitat Deymeer F, Smith TW, DeGirolami U, Drachman DA (1989) Thalamic dementia and motor neuron disease. Neurology 39:58–61PubMed Deymeer F, Smith TW, DeGirolami U, Drachman DA (1989) Thalamic dementia and motor neuron disease. Neurology 39:58–61PubMed
8.
Zurück zum Zitat Dickson DW (2001) Neuropathology of Pick’s disease. Neurology 56: S16–20PubMed Dickson DW (2001) Neuropathology of Pick’s disease. Neurology 56: S16–20PubMed
9.
Zurück zum Zitat Ferrer I, Roig C, Espino A, Peiro G, Matias Guiu X (1991) Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiatry 54:932–934PubMed Ferrer I, Roig C, Espino A, Peiro G, Matias Guiu X (1991) Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiatry 54:932–934PubMed
10.
Zurück zum Zitat Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA, Verhage MC, Sluijs JA, Hobo B, Zouambia M, Steur EN, Kamphorst W, Hol EM, Van Leeuwen FW (2003) Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17:2014–2024CrossRefPubMed Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA, Verhage MC, Sluijs JA, Hobo B, Zouambia M, Steur EN, Kamphorst W, Hol EM, Van Leeuwen FW (2003) Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17:2014–2024CrossRefPubMed
11.
Zurück zum Zitat Forno LS, Langston JW, Herrick MK, Wilson JD, Murayama S (2002) Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol 103:599–606CrossRefPubMed Forno LS, Langston JW, Herrick MK, Wilson JD, Murayama S (2002) Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol 103:599–606CrossRefPubMed
12.
Zurück zum Zitat Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J Neurosci 16:4491–4500PubMed Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J Neurosci 16:4491–4500PubMed
13.
Zurück zum Zitat Hope AD, Silva R de, Fischer DF, Hol EM, Leeuwen FW van, Lees AJ (2003) Alzheimer’s associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J Neurochem 86:394–404CrossRefPubMed Hope AD, Silva R de, Fischer DF, Hol EM, Leeuwen FW van, Lees AJ (2003) Alzheimer’s associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J Neurochem 86:394–404CrossRefPubMed
14.
Zurück zum Zitat Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572PubMed Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572PubMed
15.
Zurück zum Zitat Ikeda K, Akiyama H, Arai T, Ueno H, Tsuchiya K, Kosaka K (2002) Morphometrical reappraisal of motor neuron system of Pick’s disease and amyotrophic lateral sclerosis with dementia. Acta Neuropathol 104:21–28CrossRefPubMed Ikeda K, Akiyama H, Arai T, Ueno H, Tsuchiya K, Kosaka K (2002) Morphometrical reappraisal of motor neuron system of Pick’s disease and amyotrophic lateral sclerosis with dementia. Acta Neuropathol 104:21–28CrossRefPubMed
16.
Zurück zum Zitat Ikemoto A, Hirano A, Akiguchi I, Kimura J (1997) Comparative study of ubiquitin immunoreactivity of hippocampal granular cells in amyotrophic lateral sclerosis with dementia, Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex. Acta Neuropathol 93:265–570CrossRefPubMed Ikemoto A, Hirano A, Akiguchi I, Kimura J (1997) Comparative study of ubiquitin immunoreactivity of hippocampal granular cells in amyotrophic lateral sclerosis with dementia, Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex. Acta Neuropathol 93:265–570CrossRefPubMed
17.
Zurück zum Zitat Iseki E, Li F, Odawara T, Hino H, Suzuki K, Kosaka K, Akiyama H, Ikeda K, Kato M (1998) Ubiquitin-immunohistochemical investigation of atypical Pick’s disease without Pick bodies. J Neurol Sci 159:194–201PubMed Iseki E, Li F, Odawara T, Hino H, Suzuki K, Kosaka K, Akiyama H, Ikeda K, Kato M (1998) Ubiquitin-immunohistochemical investigation of atypical Pick’s disease without Pick bodies. J Neurol Sci 159:194–201PubMed
18.
Zurück zum Zitat Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5:339–350CrossRefPubMed Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5:339–350CrossRefPubMed
19.
Zurück zum Zitat Kawashima T, Doh-ura K, Kikuchi H, Iwaki T (2001) Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathol 102:467–472PubMed Kawashima T, Doh-ura K, Kikuchi H, Iwaki T (2001) Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathol 102:467–472PubMed
20.
Zurück zum Zitat Kertesz A, Kawarai T, Rogaeva E, St George-Hyslop P, Poorkaj P, Bird TD, Munoz DG (2000) Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54:818–827PubMed Kertesz A, Kawarai T, Rogaeva E, St George-Hyslop P, Poorkaj P, Bird TD, Munoz DG (2000) Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54:818–827PubMed
21.
Zurück zum Zitat Kinoshita A, Tomimoto H, Tachibana N, Suenaga T, Kawamata T, Kimura T, Akiguchi I, Kimura J (1996) A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex. Acta Neuropathol 92:520–524CrossRefPubMed Kinoshita A, Tomimoto H, Tachibana N, Suenaga T, Kawamata T, Kimura T, Akiguchi I, Kimura J (1996) A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex. Acta Neuropathol 92:520–524CrossRefPubMed
22.
Zurück zum Zitat Kinoshita A, Tomimoto H, Suenaga T, Akiguchi I, Kimura J (1997) Ubiquitin-related cytoskeletal abnormality in frontotemporal dementia: immunohistochemical and immunoelectron microscope studies. Acta Neuropathol 94:67–72CrossRefPubMed Kinoshita A, Tomimoto H, Suenaga T, Akiguchi I, Kimura J (1997) Ubiquitin-related cytoskeletal abnormality in frontotemporal dementia: immunohistochemical and immunoelectron microscope studies. Acta Neuropathol 94:67–72CrossRefPubMed
23.
Zurück zum Zitat Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y (1998) Upper motor neuron predominant degeneration with frontal and temporal lobe atrophy. Acta Neuropathol 96:532–536CrossRefPubMed Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y (1998) Upper motor neuron predominant degeneration with frontal and temporal lobe atrophy. Acta Neuropathol 96:532–536CrossRefPubMed
24.
Zurück zum Zitat Kövari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J, Bouras C (2000) Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol 100:421–426PubMed Kövari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J, Bouras C (2000) Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol 100:421–426PubMed
25.
Zurück zum Zitat Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol 106:83–88PubMed Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson’s disease. Acta Neuropathol 106:83–88PubMed
26.
Zurück zum Zitat Lang-Rollin I, Rideout H, Stefanis L (2003) Ubiquitinated inclusions and neuronal cell death. Histol Histopathol 18:509–517PubMed Lang-Rollin I, Rideout H, Stefanis L (2003) Ubiquitinated inclusions and neuronal cell death. Histol Histopathol 18:509–517PubMed
27.
Zurück zum Zitat Mackenzie IR, Feldman H (2004) Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study. Acta Neuropathol 107:336–340CrossRefPubMed Mackenzie IR, Feldman H (2004) Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study. Acta Neuropathol 107:336–340CrossRefPubMed
28.
Zurück zum Zitat Mann DM, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56:605–614PubMed Mann DM, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56:605–614PubMed
29.
Zurück zum Zitat Martin JA, Craft DK, Su JH, Kim RC, Cotman CW (2001) Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion. Neurobiol Aging 22:195–207CrossRefPubMed Martin JA, Craft DK, Su JH, Kim RC, Cotman CW (2001) Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion. Neurobiol Aging 22:195–207CrossRefPubMed
30.
Zurück zum Zitat McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 58:1803–1809PubMed McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 58:1803–1809PubMed
31.
Zurück zum Zitat Mochizuki A, Komatsuzaki Y, Iwamoto H, Shoji S (2004) Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case. Acta Neuropathol 107:337–380CrossRef Mochizuki A, Komatsuzaki Y, Iwamoto H, Shoji S (2004) Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case. Acta Neuropathol 107:337–380CrossRef
32.
Zurück zum Zitat Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554PubMed Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554PubMed
33.
Zurück zum Zitat Nichol KE, Kim R, Cotman CW (2001) Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement. Neurology 56:S35–40CrossRef Nichol KE, Kim R, Cotman CW (2001) Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement. Neurology 56:S35–40CrossRef
34.
Zurück zum Zitat Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, Hino H, Furukawa Y, Kato M, Yamamoto T, Kosaka K (2003) Clinicopathological study of two subtypes of Pick’s disease in Japan. Dement Geriatr Cogn Disord 15:19–25CrossRefPubMed Odawara T, Iseki E, Kanai A, Arai T, Katsuragi T, Hino H, Furukawa Y, Kato M, Yamamoto T, Kosaka K (2003) Clinicopathological study of two subtypes of Pick’s disease in Japan. Dement Geriatr Cogn Disord 15:19–25CrossRefPubMed
35.
Zurück zum Zitat Rosso SM, Kamphorst W, Graaf B de, Willemsen R, Ravid R, Niermeijer MF, Spillantini MG, Heutink P, Swieten JC van (2001) Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21–22. Brain 124:1948–1957PubMed Rosso SM, Kamphorst W, Graaf B de, Willemsen R, Ravid R, Niermeijer MF, Spillantini MG, Heutink P, Swieten JC van (2001) Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21–22. Brain 124:1948–1957PubMed
36.
Zurück zum Zitat Rosso SM, Donker Kaat L, Baks T, Joosse M, Koning I de, Pijnenburg Y, Jong D de, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, Duijn CM van, Heutink P, Swieten JC van (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126:2016–2022CrossRefPubMed Rosso SM, Donker Kaat L, Baks T, Joosse M, Koning I de, Pijnenburg Y, Jong D de, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, Duijn CM van, Heutink P, Swieten JC van (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126:2016–2022CrossRefPubMed
37.
Zurück zum Zitat Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127–136PubMed Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127–136PubMed
38.
Zurück zum Zitat Su JH, Nichol KE, Sitch T, Sheu P, Chubb C, Miller BL, Tomaselli KJ, Kim RC, Cotman CW (2000) DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp Neurol 163:9–19CrossRefPubMed Su JH, Nichol KE, Sitch T, Sheu P, Chubb C, Miller BL, Tomaselli KJ, Kim RC, Cotman CW (2000) DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp Neurol 163:9–19CrossRefPubMed
39.
Zurück zum Zitat Talbot PR (1996) Frontal lobe dementia and motor neuron disease. J Neural Transm Suppl 47:125–132PubMed Talbot PR (1996) Frontal lobe dementia and motor neuron disease. J Neural Transm Suppl 47:125–132PubMed
40.
Zurück zum Zitat Tolnay M, Probst A (1995) Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492–497PubMed Tolnay M, Probst A (1995) Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492–497PubMed
41.
Zurück zum Zitat Tolnay M, Probst A (2001) Frontotemporal lobar degeneration. An update on clinical, pathological and genetic findings. Gerontology 47:1–8CrossRef Tolnay M, Probst A (2001) Frontotemporal lobar degeneration. An update on clinical, pathological and genetic findings. Gerontology 47:1–8CrossRef
42.
Zurück zum Zitat Toyoshima Y, Piao YS, Tan CF, Morita M, Tanaka M, Oyanagi K, Okamoto K, Takahashi H (2003) Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia. Acta Neuropathol 106:50–56PubMed Toyoshima Y, Piao YS, Tan CF, Morita M, Tanaka M, Oyanagi K, Okamoto K, Takahashi H (2003) Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia. Acta Neuropathol 106:50–56PubMed
43.
Zurück zum Zitat West MJ (1993) New stereological methods for counting neurons. Neurobiol Aging 14:275–285PubMed West MJ (1993) New stereological methods for counting neurons. Neurobiol Aging 14:275–285PubMed
44.
Zurück zum Zitat West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet 344:769–772PubMed West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet 344:769–772PubMed
45.
Zurück zum Zitat Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269–274PubMed Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269–274PubMed
46.
Zurück zum Zitat Woulfe J, Kertesz A, Munoz DG (2001) Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol 102:94–102PubMed Woulfe J, Kertesz A, Munoz DG (2001) Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol 102:94–102PubMed
47.
Zurück zum Zitat Yaguchi M, Okamoto K, Nakazato Y (2003) Frontotemporal dementia with cerebral intraneuronal ubiquitin-positive inclusions but lacking lower motor neuron involvement. Acta Neuropathol 105:81–85PubMed Yaguchi M, Okamoto K, Nakazato Y (2003) Frontotemporal dementia with cerebral intraneuronal ubiquitin-positive inclusions but lacking lower motor neuron involvement. Acta Neuropathol 105:81–85PubMed
48.
Zurück zum Zitat Yang Y, Schmitt HP (2001) Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol 101:256–270PubMed Yang Y, Schmitt HP (2001) Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol 101:256–270PubMed
49.
Zurück zum Zitat Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 49:165–175PubMed Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 49:165–175PubMed
Metadaten
Titel
Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study
verfasst von
Enikö Kövari
Gabriel Gold
Panteleimon Giannakopoulos
Constantin Bouras
Publikationsdatum
01.09.2004
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2004
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-004-0881-8

Weitere Artikel der Ausgabe 3/2004

Acta Neuropathologica 3/2004 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.